Bases epidemiológicas - Tuberculosis

233. B a rnett GD, G r z y b owski S, S t y blo K. Present risk of developing active tuberculosis inS a s k at ch ewan according to previous tuberculin and X-ray status. Bull. Int. Union Tu b e rc. ,1971; 45: 51-74.234. M i dd l eb rook G, Cohn ML. Some observations on the pat h ogenicity of isoniazid-re s i s t a n tvariants of tubercle bacilli. Science, 1953; 118: 297-9.235. M i t chison DA , Wallace JG, B h atia A L ,S e l kon JB, S u bbaiah T V, Lancaster MC. A compari s o nof the virulence in guinea-pigs of South Indian and British tubercle bacilli. Tu b e rcl e, 1 9 6 0 ;4 1 : 1 - 2 2 .236. D i ckinson JM, L e ffo rd MJ, L l oyd J, M i t chison DA. The virulence in the guinea-pig oft u b e rcle bacilli from patients with pulmonary tuberculosis in Hong Ko n g. Tu b e rcl e, 1 9 6 3 ;4 4 : 4 4 6 - 5 1 .237. B a l a s u b ramanian V, Guo-Zhi W, Wi egeshaus E, Smith D. Vi rulence of M y c o b a c t e ri u mtuberculosis for guinea pigs: a quantitative modification of the assay developed by Mitchison.Tubercle Lung Dis., 1992; 73: 268-72.238. G ra n ge JM. Vi rulence of M y c o b a c t e rium tuberc u l o s i s. FEMS Microbiol. Rev. , 1985; 32: 5 5 - 6 0 .239. O rdway DJ, S o n n e n b e rg MG, Donahue SA, Belisle JT, O rme IM. Dru g - resistant strains ofM y c o b a c t e rium tuberculosis exhibit a ra n ge of virulence for mice. Infect. Immu n i t y, 1995; 63:741-3.240. Va lway SE, S a n chez MPC, S h i n n i ck T F, O rme I, A ge rton T, H oy D, et al. An outbreak invo l v i n gextensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med.,1998; 338: 633-9.241. A rvanitakis Z, Long RL, H e rs h field ES, M a n f reda J, K abani A , Kunimoto D, et al.M . t u b e rc u l o s i s molecular va ri ation in CNS infection. Evidence for stra i n - d ep e n d e n tneurovirulence. Neurology, 1998; 50: 1827-32.242. Mitchison DA. Drug resistance in mycobacteria. Br. Med. Bull., 1984; 40: 84-90.243. Li Z, Ke l l ey C, Collins F, Rouse D, M o rris S. Expression of katG in M y c o b a c t e rium tuberc u l o s i sis associated with its growth and persistence in mice and guinea pigs. J. Infect. Dis.,1998; 177: 1030-5.244. Wilson TM, De Lisle GW, Collins DM. Effect of inhA and katG on isoniazid resistance andvirulence of Mycobacterium bovis. Mol. Microbiol., 1995; 15: 1009-15.245. Frieden T R , F u j i wa ra PI, Wa s h ko RM, H a m bu rg MA. Tu b e rculosis in New Yo rk City - turn i n gthe tide. N. Engl. J. Med., 1995; 333: 229-33.246. Fujiwara PI, Cook SV, Rutherford CM, Crawford JT, Glickman SE, Kreiswirth BN, et al. Ac o n t i nuing survey of dru g - resistant tuberc u l o s i s , N ew Yo rk City, Ap ril 1994. A rch. Intern .Med., 1997; 157: 531-6.247. Davies J. Antibiotic resistance in mycobacteria. Novartis Found Symp., 1998; 217: 195-208.248. H e i m b e ck J. Sur la va c c i n ation préve n t ive de la tuberculose par injection sous-cutanée de BCGchez les élève s - i n fi rm i è res de l'hôpital Ulleva l , à Oslo (Norv è ge). Ann. Inst. Pa s t e u r, 1928; 42:1229-32.- 162 -